Profile data is unavailable for this security.
About the company
Bausch + Lomb Corporation is an eye health company. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. The Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
- Revenue in USD (TTM)4.31bn
- Net income in USD-337.00m
- Incorporated2020
- Employees13.30k
- LocationBausch + Lomb Corp520 Applewood CrescentVAUGHAN L4K 4B4CanadaCAN
- Websitehttps://ir.bausch.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Procept Biorobotics Corp | 156.33m | -103.37m | 3.25bn | 626.00 | -- | 12.30 | -- | 20.78 | -2.12 | -2.12 | 3.20 | 5.14 | 0.4685 | 1.81 | 4.08 | 249,722.00 | -30.98 | -- | -34.68 | -- | 53.47 | -- | -66.12 | -- | 7.44 | -- | 0.1629 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| Axonics Inc | 387.14m | -15.95m | 3.43bn | 797.00 | -- | 5.47 | -- | 8.86 | -0.3134 | -0.3134 | 7.76 | 12.29 | 0.5606 | 1.20 | 8.53 | 485,744.00 | -2.31 | -12.67 | -2.52 | -13.76 | 75.25 | 70.04 | -4.12 | -29.68 | 8.04 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
| Integer Holdings Corp | 1.63bn | 98.09m | 3.90bn | 10.50k | 40.39 | 2.56 | 19.58 | 2.39 | 2.88 | 2.88 | 47.86 | 45.52 | 0.5452 | 4.91 | 4.95 | 155,494.60 | 3.28 | 3.28 | 3.53 | 3.53 | 26.54 | 26.94 | 6.01 | 6.40 | 2.01 | 3.74 | 0.4303 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| Haemonetics Corporation | 1.31bn | 117.56m | 4.30bn | 3.66k | 37.01 | 4.48 | 20.04 | 3.29 | 2.29 | 2.29 | 25.47 | 18.90 | 0.6339 | 2.10 | 6.79 | 357,958.70 | 5.69 | 5.02 | 6.57 | 6.07 | 53.69 | 51.74 | 8.98 | 8.11 | 1.50 | 18.09 | 0.457 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
| TransMedics Group Inc | 296.92m | -10.20m | 4.68bn | 584.00 | -- | 29.25 | 4,271.62 | 15.75 | -0.335 | -0.335 | 8.96 | 4.85 | 0.5874 | 3.08 | 4.93 | 508,422.90 | -2.02 | -16.08 | -2.19 | -17.95 | 62.40 | 65.37 | -3.43 | -40.47 | 8.76 | -- | 0.7607 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
| Merit Medical Systems Inc | 1.28bn | 101.95m | 4.75bn | 6.95k | 46.90 | 3.83 | 24.38 | 3.70 | 1.74 | 1.74 | 21.96 | 21.35 | 0.64 | 2.32 | 7.32 | 184,648.80 | 5.08 | 2.45 | 5.65 | 2.77 | 46.54 | 44.50 | 7.94 | 3.91 | 4.38 | 11.61 | 0.3922 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Inspire Medical Systems Inc | 660.91m | -15.73m | 4.95bn | 1.01k | -- | 8.40 | -- | 7.49 | -0.5374 | -0.5374 | 22.46 | 19.85 | 1.05 | 3.14 | 10.01 | 653,721.10 | -2.50 | -11.27 | -2.80 | -12.60 | 84.65 | 84.47 | -2.38 | -13.57 | 7.25 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Bausch + Lomb Corp | 4.31bn | -337.00m | 5.31bn | 13.30k | -- | 0.7963 | 68.07 | 1.23 | -0.9603 | -0.9603 | 12.30 | 18.95 | 0.3527 | 1.91 | 5.28 | 324,360.90 | -2.64 | -- | -3.01 | -- | 60.73 | 61.63 | -7.49 | 1.30 | 1.03 | 0.6549 | 0.4052 | 0.00 | 10.03 | 2.50 | -4,433.33 | -- | 12.38 | -- |
| Stevanato Group SpA | 1.16bn | 145.70m | 5.36bn | 5.64k | 32.34 | -- | 28.24 | 4.63 | 0.5494 | 0.5494 | 4.37 | -- | -- | -- | -- | 205,713.70 | -- | -- | -- | -- | 30.81 | -- | 12.57 | -- | -- | 32.91 | -- | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| DENTSPLY SIRONA Inc | 3.94bn | -95.00m | 5.42bn | 15.00k | -- | 1.66 | 21.43 | 1.38 | -0.4468 | -0.4468 | 18.69 | 15.69 | 0.5326 | 2.94 | 6.02 | 262,666.70 | -1.24 | -1.14 | -1.52 | -1.32 | 52.61 | 53.65 | -2.34 | -2.51 | 0.9692 | 3.27 | 0.3908 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| Lantheus Holdings Inc | 1.37bn | 460.53m | 5.49bn | 834.00 | 12.10 | 5.81 | 10.54 | 4.02 | 6.55 | 6.55 | 19.42 | 13.64 | 0.8587 | 8.78 | 4.71 | 1,637,434.00 | 28.96 | 6.69 | 34.54 | 7.73 | 64.02 | 53.90 | 33.72 | 9.02 | 4.55 | -- | 0.3733 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Glaukos Corp | 326.43m | -140.87m | 5.67bn | 907.00 | -- | 12.45 | -- | 17.37 | -2.88 | -2.88 | 6.68 | 9.04 | 0.3426 | 1.72 | 7.74 | 359,905.20 | -14.78 | -8.73 | -15.91 | -9.35 | 76.18 | 74.77 | -43.16 | -28.69 | 4.68 | -38.38 | 0.4395 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Novanta Inc | 893.45m | 69.29m | 5.79bn | 2.90k | 83.92 | 8.49 | 49.43 | 6.48 | 1.92 | 1.92 | 24.77 | 18.99 | 0.6778 | 2.99 | 6.11 | 308,086.90 | 5.26 | 5.46 | 5.92 | 6.34 | 45.07 | 43.24 | 7.76 | 7.71 | 1.77 | 4.42 | 0.4319 | 0.00 | 2.41 | 7.49 | -1.58 | 8.21 | 4.19 | -- |
| MSA Safety Inc | 1.80bn | 266.82m | 7.01bn | 5.10k | 26.45 | 7.07 | 21.33 | 3.89 | 6.73 | 6.73 | 45.49 | 25.26 | 0.8281 | 2.86 | 6.45 | 353,467.80 | 12.26 | 5.08 | 14.25 | 6.00 | 48.05 | 45.21 | 14.81 | 7.02 | 1.54 | 6.50 | 0.3747 | 65.91 | 17.00 | 5.65 | -67.41 | -13.66 | 4.72 | -1.10 |
| Masimo Corp | 1.98bn | 79.10m | 7.20bn | 3.80k | 92.68 | 5.28 | 41.04 | 3.65 | 1.46 | 1.46 | 36.54 | 25.71 | 0.6507 | 2.01 | 5.24 | 519,973.70 | 2.60 | 8.65 | 3.17 | 10.31 | 48.61 | 57.30 | 4.00 | 12.03 | 1.31 | 3.61 | 0.3909 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
| Penumbra Inc | 1.10bn | 93.39m | 7.28bn | 4.20k | 79.00 | 6.05 | 59.86 | 6.64 | 2.38 | 2.38 | 27.90 | 31.05 | 0.7366 | 1.03 | 5.49 | 260,899.80 | 6.28 | 2.32 | 6.98 | 2.61 | 65.04 | 63.90 | 8.52 | 3.17 | 3.51 | -- | 0.0207 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
Data as of Jun 17 2024. Currency figures normalised to Bausch + Lomb Corp's reporting currency: US Dollar USD
8.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Investments Canada ULCas of 31 Mar 2024 | 8.19m | 2.33% |
| GoldenTree Asset Management LPas of 31 Mar 2024 | 4.72m | 1.34% |
| Maple Rock Capital Partners, Inc.as of 31 Mar 2024 | 3.75m | 1.07% |
| Icahn Associates Holding LLCas of 31 Mar 2024 | 3.50m | 1.00% |
| River Road Asset Management LLCas of 31 Mar 2024 | 1.89m | 0.54% |
| Alberta Investment Management Corp.as of 31 Mar 2024 | 1.59m | 0.45% |
| Citadel Advisors LLCas of 31 Mar 2024 | 1.41m | 0.40% |
| Nomura Securities Co., Ltd. (Private Banking)as of 31 Mar 2024 | 1.26m | 0.36% |
| Whitebox Advisors LLCas of 31 Mar 2024 | 1.21m | 0.34% |
| Freshford Capital Management LLCas of 31 Mar 2024 | 1.17m | 0.33% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
